Prevalence of urinary incontinence and prolapse after hysterectomy for benign disease versus gynecologic malignancy.

Jeannine M Miranne, Iwona Gabriel, Maura Kelly, Alexa Courtepatte, Vatche A Minassian
{"title":"Prevalence of urinary incontinence and prolapse after hysterectomy for benign disease versus gynecologic malignancy.","authors":"Jeannine M Miranne, Iwona Gabriel, Maura Kelly, Alexa Courtepatte, Vatche A Minassian","doi":"10.5603/gpl.98184","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To estimate the prevalence of UI and POP after hysterectomy for benign disease and gynecologic malignancy. This is a retrospective cohort chart review study. Two major urban tertiary care centers between 2006-2010. Women ≥ 18 years undergoing hysterectomy for benign or malignant indications.</p><p><strong>Material and methods: </strong>Presence of UI and POP was based on patient report in clinic notes, ICD-9 UI and POP diagnosis codes, and CPT codes for treatment. Prevalence of UI and POP after hysterectomy and time to development of UI and POP after hysterectomy.</p><p><strong>Results: </strong>1363 (55%) women underwent hysterectomy for benign disease while 1107 (45%) had a hysterectomy for malignancy. Postoperative prevalence of UI and POP in the benign versus the malignant group was 15.1% vs 11.1% (p = 0.001), and 12.1% vs 2.8%, (p < 0.001), respectively. The median time to development of UI in the subset of patients without preoperative UI was 3.5 years in the benign group vs 3 years in the malignant group (p < 0.001). The median time to development of POP in the subset of patients without preoperative POP was 5 years in the benign group and 3.5 years in the malignant group (p < 0.001). There was no significant difference in the risk of developing UI or POP between groups after adjusting for confounders or when accounting for pre-hysterectomy UI or POP.</p><p><strong>Conclusions: </strong>When pre-hysterectomy UI or POP is taken into consideration, there is no difference in the prevalence of post-hysterectomy UI or POP.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ginekologia polska","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/gpl.98184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To estimate the prevalence of UI and POP after hysterectomy for benign disease and gynecologic malignancy. This is a retrospective cohort chart review study. Two major urban tertiary care centers between 2006-2010. Women ≥ 18 years undergoing hysterectomy for benign or malignant indications.

Material and methods: Presence of UI and POP was based on patient report in clinic notes, ICD-9 UI and POP diagnosis codes, and CPT codes for treatment. Prevalence of UI and POP after hysterectomy and time to development of UI and POP after hysterectomy.

Results: 1363 (55%) women underwent hysterectomy for benign disease while 1107 (45%) had a hysterectomy for malignancy. Postoperative prevalence of UI and POP in the benign versus the malignant group was 15.1% vs 11.1% (p = 0.001), and 12.1% vs 2.8%, (p < 0.001), respectively. The median time to development of UI in the subset of patients without preoperative UI was 3.5 years in the benign group vs 3 years in the malignant group (p < 0.001). The median time to development of POP in the subset of patients without preoperative POP was 5 years in the benign group and 3.5 years in the malignant group (p < 0.001). There was no significant difference in the risk of developing UI or POP between groups after adjusting for confounders or when accounting for pre-hysterectomy UI or POP.

Conclusions: When pre-hysterectomy UI or POP is taken into consideration, there is no difference in the prevalence of post-hysterectomy UI or POP.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
良性疾病与妇科恶性肿瘤子宫切除术后尿失禁和脱垂的发生率。
目的估计良性疾病和妇科恶性肿瘤子宫切除术后 UI 和 POP 的发病率。这是一项回顾性队列病历审查研究。研究对象为 2006-2010 年间两个主要的城市三级医疗中心。因良性或恶性指征接受子宫切除术的≥18岁女性:根据患者在门诊笔记中的报告、ICD-9 UI 和 POP 诊断代码以及 CPT 治疗代码确定是否存在 UI 和 POP。子宫切除术后 UI 和 POP 的发病率以及子宫切除术后 UI 和 POP 的发病时间:1363名(55%)妇女因良性疾病接受了子宫切除术,1107名(45%)妇女因恶性肿瘤接受了子宫切除术。良性组与恶性组的术后尿失禁和子宫内膜异位症发病率分别为 15.1% 对 11.1% (P = 0.001)和 12.1% 对 2.8% (P < 0.001)。在没有术前UI的患者子集中,良性组发生UI的中位时间为3.5年,而恶性组为3年(P < 0.001)。在没有术前POP的患者子集中,良性组发生POP的中位时间为5年,恶性组为3.5年(P < 0.001)。在对混杂因素进行调整后,或考虑到子宫切除术前UI或POP时,各组间发生UI或POP的风险无明显差异:结论:如果考虑到子宫切除术前的 UI 或 POP,子宫切除术后 UI 或 POP 的发病率没有差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A case of a patient at reproductive age with BRCA2 and CHEK2 mutations and multiple uterine fibroids. Breastfeeding myths - the prevalence among the population of Polish women. Clinical application of Synthetic Osmotic Cervical Dilator in labor pre-induction: departmental protocol and literature review. Comparison of the efficacy and safety of dinoprostone and double-balloon catheters in cervical ripening: a propensity score matching retrospective study. Placenta accreta spectrum (PAS) - prenatal diagnosis and management. The Polish Society of Gynecologists and Obstetricians Guidelines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1